![A. Mark Dyas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
A. Mark Dyas worked as a Director of Pharmaceutical Development at Veloxis Pharmaceuticals A and as a Director & Chief Scientific Officer at IOTA NanoSolutions Ltd.
| Companies | Position | End |
|---|---|---|
IOTA NanoSolutions Ltd.
 IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Chief Tech/Sci/R&D Officer | 10/10/2013 |
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
IOTA NanoSolutions Ltd.
IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Process Industries |
Select your edition
All financial news and data tailored to specific country editions
